Loading clinical trials...
Loading clinical trials...
Effect of High Dose vs. Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3, High Viral Load Without Rapid Virological Response
Conditions
Interventions
Peginterferon alfa 2 A
Peginterferon alfa 2 A, ribavirin + Epo Beta
+4 more
Locations
28
Spain
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital del Mar
Barcelona, Barcelona, Spain
Hospital Clinic i Provincial de Barcelona
Barcelona, Barcelona, Spain
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Parc Taulí
Sabadell, Barcelona, Spain
Hospital Marqués de Valdecilla
Santander, Cantabria, Spain
Start Date
November 1, 2008
Primary Completion Date
September 1, 2011
Completion Date
December 1, 2011
Last Updated
March 13, 2012
NCT00199719
NCT06922643
NCT03612973
NCT01866930
NCT05895448
NCT02219490
Lead Sponsor
Dr. Conrado Fernandez
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions